Scholars Central

Conference abstractPublished 23 Jun 2023

Biotech and biopharma sectors

Authors: Andreu Soldevila Fabrega

LeanBio, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A biopharmaceutical, also known as a biological medical product (or) biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living medicines used in cell therapy. Biologics can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living cells or tissues. They (or) their precursors or components) are isolated from living sources human, animal, plant, fungal, or microbial. They can be used in both human and animal medicine.’

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Biomedical and Pharmaceutical Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Biomedical and Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Andreu Soldevila Fabrega”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels